- REPORT SUMMARY
- TABLE OF CONTENTS
-
t is a private or institutional investment made into early-stage / start-up companies (new ventures). As defined, ventures involve risk (having uncertain outcome) in the expectation of a sizeable gain. Venture Capital is money invested in businesses that are small; or exist only as an initiative, but have huge potential to grow. The people who invest this money are called venture capitalists (VCs). The venture capital investment is made when a venture capitalist buys shares of such a company and becomes a financial partner in the business.
Patient Risk Capital Investment market report explains the definition, types, applications, major countries, and major players of the Patient Risk Capital Investment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
UNION SQUARE VENTURES
Accel
Breyer Capital
Bessemer Venture Partners
Sequoia Capital
Index Ventures
New Enterprise Associates
Greylock Partners
First Round Capital
Benchmark Capital
Founders Fund
Kleiner Perkins Caufield Byers
Lowercase Capital
Baseline Ventures
Andreessen Horowitz
By Type:
Early Stage Financing
Expansion Financing
Acquisition or Buyout Financing
By End-User:
High Technology Industries
Innovative Technology Company
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Patient Risk Capital Investment Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Patient Risk Capital Investment Outlook to 2028- Original Forecasts
-
2.2 Patient Risk Capital Investment Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Patient Risk Capital Investment Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Patient Risk Capital Investment Market- Recent Developments
-
6.1 Patient Risk Capital Investment Market News and Developments
-
6.2 Patient Risk Capital Investment Market Deals Landscape
7 Patient Risk Capital Investment Raw Materials and Cost Structure Analysis
-
7.1 Patient Risk Capital Investment Key Raw Materials
-
7.2 Patient Risk Capital Investment Price Trend of Key Raw Materials
-
7.3 Patient Risk Capital Investment Key Suppliers of Raw Materials
-
7.4 Patient Risk Capital Investment Market Concentration Rate of Raw Materials
-
7.5 Patient Risk Capital Investment Cost Structure Analysis
-
7.5.1 Patient Risk Capital Investment Raw Materials Analysis
-
7.5.2 Patient Risk Capital Investment Labor Cost Analysis
-
7.5.3 Patient Risk Capital Investment Manufacturing Expenses Analysis
8 Global Patient Risk Capital Investment Import and Export Analysis (Top 10 Countries)
-
8.1 Global Patient Risk Capital Investment Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Patient Risk Capital Investment Export by Region (Top 10 Countries) (2017-2028)
9 Global Patient Risk Capital Investment Market Outlook by Types and Applications to 2022
-
9.1 Global Patient Risk Capital Investment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Early Stage Financing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Expansion Financing Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Acquisition or Buyout Financing Consumption and Growth Rate (2017-2022)
-
9.2 Global Patient Risk Capital Investment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global High Technology Industries Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Innovative Technology Company Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Patient Risk Capital Investment Market Analysis and Outlook till 2022
-
10.1 Global Patient Risk Capital Investment Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Patient Risk Capital Investment Consumption (2017-2022)
-
10.2.2 Canada Patient Risk Capital Investment Consumption (2017-2022)
-
10.2.3 Mexico Patient Risk Capital Investment Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.2 UK Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.3 Spain Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.4 Belgium Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.5 France Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.6 Italy Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.7 Denmark Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.8 Finland Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.9 Norway Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.10 Sweden Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.11 Poland Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.12 Russia Patient Risk Capital Investment Consumption (2017-2022)
-
10.3.13 Turkey Patient Risk Capital Investment Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.2 Japan Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.3 India Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.4 South Korea Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.5 Pakistan Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.6 Bangladesh Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.7 Indonesia Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.8 Thailand Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.9 Singapore Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.10 Malaysia Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.11 Philippines Patient Risk Capital Investment Consumption (2017-2022)
-
10.4.12 Vietnam Patient Risk Capital Investment Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.2 Colombia Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.3 Chile Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.4 Argentina Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.5 Venezuela Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.6 Peru Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.7 Puerto Rico Patient Risk Capital Investment Consumption (2017-2022)
-
10.5.8 Ecuador Patient Risk Capital Investment Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Patient Risk Capital Investment Consumption (2017-2022)
-
10.6.2 Kuwait Patient Risk Capital Investment Consumption (2017-2022)
-
10.6.3 Oman Patient Risk Capital Investment Consumption (2017-2022)
-
10.6.4 Qatar Patient Risk Capital Investment Consumption (2017-2022)
-
10.6.5 Saudi Arabia Patient Risk Capital Investment Consumption (2017-2022)
-
10.6.6 United Arab Emirates Patient Risk Capital Investment Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Patient Risk Capital Investment Consumption (2017-2022)
-
10.7.2 South Africa Patient Risk Capital Investment Consumption (2017-2022)
-
10.7.3 Egypt Patient Risk Capital Investment Consumption (2017-2022)
-
10.7.4 Algeria Patient Risk Capital Investment Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Patient Risk Capital Investment Consumption (2017-2022)
-
10.8.2 New Zealand Patient Risk Capital Investment Consumption (2017-2022)
11 Global Patient Risk Capital Investment Competitive Analysis
-
11.1 UNION SQUARE VENTURES
-
11.1.1 UNION SQUARE VENTURES Company Details
-
11.1.2 UNION SQUARE VENTURES Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 UNION SQUARE VENTURES Patient Risk Capital Investment Main Business and Markets Served
-
11.1.4 UNION SQUARE VENTURES Patient Risk Capital Investment Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Accel
-
11.2.1 Accel Company Details
-
11.2.2 Accel Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Accel Patient Risk Capital Investment Main Business and Markets Served
-
11.2.4 Accel Patient Risk Capital Investment Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Breyer Capital
-
11.3.1 Breyer Capital Company Details
-
11.3.2 Breyer Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Breyer Capital Patient Risk Capital Investment Main Business and Markets Served
-
11.3.4 Breyer Capital Patient Risk Capital Investment Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bessemer Venture Partners
-
11.4.1 Bessemer Venture Partners Company Details
-
11.4.2 Bessemer Venture Partners Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bessemer Venture Partners Patient Risk Capital Investment Main Business and Markets Served
-
11.4.4 Bessemer Venture Partners Patient Risk Capital Investment Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Sequoia Capital
-
11.5.1 Sequoia Capital Company Details
-
11.5.2 Sequoia Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Sequoia Capital Patient Risk Capital Investment Main Business and Markets Served
-
11.5.4 Sequoia Capital Patient Risk Capital Investment Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Index Ventures
-
11.6.1 Index Ventures Company Details
-
11.6.2 Index Ventures Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Index Ventures Patient Risk Capital Investment Main Business and Markets Served
-
11.6.4 Index Ventures Patient Risk Capital Investment Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 New Enterprise Associates
-
11.7.1 New Enterprise Associates Company Details
-
11.7.2 New Enterprise Associates Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 New Enterprise Associates Patient Risk Capital Investment Main Business and Markets Served
-
11.7.4 New Enterprise Associates Patient Risk Capital Investment Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Greylock Partners
-
11.8.1 Greylock Partners Company Details
-
11.8.2 Greylock Partners Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Greylock Partners Patient Risk Capital Investment Main Business and Markets Served
-
11.8.4 Greylock Partners Patient Risk Capital Investment Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 First Round Capital
-
11.9.1 First Round Capital Company Details
-
11.9.2 First Round Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 First Round Capital Patient Risk Capital Investment Main Business and Markets Served
-
11.9.4 First Round Capital Patient Risk Capital Investment Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Benchmark Capital
-
11.10.1 Benchmark Capital Company Details
-
11.10.2 Benchmark Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Benchmark Capital Patient Risk Capital Investment Main Business and Markets Served
-
11.10.4 Benchmark Capital Patient Risk Capital Investment Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Founders Fund
-
11.11.1 Founders Fund Company Details
-
11.11.2 Founders Fund Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Founders Fund Patient Risk Capital Investment Main Business and Markets Served
-
11.11.4 Founders Fund Patient Risk Capital Investment Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Kleiner Perkins Caufield Byers
-
11.12.1 Kleiner Perkins Caufield Byers Company Details
-
11.12.2 Kleiner Perkins Caufield Byers Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Kleiner Perkins Caufield Byers Patient Risk Capital Investment Main Business and Markets Served
-
11.12.4 Kleiner Perkins Caufield Byers Patient Risk Capital Investment Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Lowercase Capital
-
11.13.1 Lowercase Capital Company Details
-
11.13.2 Lowercase Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Lowercase Capital Patient Risk Capital Investment Main Business and Markets Served
-
11.13.4 Lowercase Capital Patient Risk Capital Investment Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Baseline Ventures
-
11.14.1 Baseline Ventures Company Details
-
11.14.2 Baseline Ventures Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Baseline Ventures Patient Risk Capital Investment Main Business and Markets Served
-
11.14.4 Baseline Ventures Patient Risk Capital Investment Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Andreessen Horowitz
-
11.15.1 Andreessen Horowitz Company Details
-
11.15.2 Andreessen Horowitz Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Andreessen Horowitz Patient Risk Capital Investment Main Business and Markets Served
-
11.15.4 Andreessen Horowitz Patient Risk Capital Investment Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global Patient Risk Capital Investment Market Outlook by Types and Applications to 2028
-
12.1 Global Patient Risk Capital Investment Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Early Stage Financing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Expansion Financing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Acquisition or Buyout Financing Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Patient Risk Capital Investment Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global High Technology Industries Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Innovative Technology Company Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Patient Risk Capital Investment Market Analysis and Outlook to 2028
-
13.1 Global Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.2.2 Canada Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.2.3 Mexico Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.2 UK Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.3 Spain Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.4 Belgium Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.5 France Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.6 Italy Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.7 Denmark Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.8 Finland Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.9 Norway Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.10 Sweden Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.11 Poland Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.12 Russia Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.3.13 Turkey Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.2 Japan Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.3 India Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.4 South Korea Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.8 Thailand Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.9 Singapore Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.11 Philippines Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.2 Colombia Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.3 Chile Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.4 Argentina Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.6 Peru Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.6.3 Oman Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.6.4 Qatar Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.7.2 South Africa Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.7.3 Egypt Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.7.4 Algeria Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Patient Risk Capital Investment Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Patient Risk Capital Investment Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Patient Risk Capital Investment
-
Figure of Patient Risk Capital Investment Picture
-
Table Global Patient Risk Capital Investment Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Patient Risk Capital Investment Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Early Stage Financing Consumption and Growth Rate (2017-2022)
-
Figure Global Expansion Financing Consumption and Growth Rate (2017-2022)
-
Figure Global Acquisition or Buyout Financing Consumption and Growth Rate (2017-2022)
-
Figure Global High Technology Industries Consumption and Growth Rate (2017-2022)
-
Figure Global Innovative Technology Company Consumption and Growth Rate (2017-2022)
-
Figure Global Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Table North America Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure United States Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Canada Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Mexico Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table Europe Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure Germany Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure UK Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Spain Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Belgium Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure France Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Italy Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Denmark Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Finland Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Norway Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Sweden Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Poland Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Russia Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Turkey Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table APAC Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure China Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Japan Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure India Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Thailand Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Singapore Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Philippines Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table South America Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure Brazil Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Colombia Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Chile Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Argentina Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Peru Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table GCC Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure Bahrain Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Oman Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Qatar Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table Africa Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure Nigeria Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure South Africa Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Egypt Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure Algeria Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table Oceania Patient Risk Capital Investment Consumption by Country (2017-2022)
-
Figure Australia Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Patient Risk Capital Investment Consumption and Growth Rate (2017-2022)
-
Table UNION SQUARE VENTURES Company Details
-
Table UNION SQUARE VENTURES Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table UNION SQUARE VENTURES Patient Risk Capital Investment Main Business and Markets Served
-
Table UNION SQUARE VENTURES Patient Risk Capital Investment Product Portfolio
-
Table Accel Company Details
-
Table Accel Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Accel Patient Risk Capital Investment Main Business and Markets Served
-
Table Accel Patient Risk Capital Investment Product Portfolio
-
Table Breyer Capital Company Details
-
Table Breyer Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Breyer Capital Patient Risk Capital Investment Main Business and Markets Served
-
Table Breyer Capital Patient Risk Capital Investment Product Portfolio
-
Table Bessemer Venture Partners Company Details
-
Table Bessemer Venture Partners Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bessemer Venture Partners Patient Risk Capital Investment Main Business and Markets Served
-
Table Bessemer Venture Partners Patient Risk Capital Investment Product Portfolio
-
Table Sequoia Capital Company Details
-
Table Sequoia Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sequoia Capital Patient Risk Capital Investment Main Business and Markets Served
-
Table Sequoia Capital Patient Risk Capital Investment Product Portfolio
-
Table Index Ventures Company Details
-
Table Index Ventures Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Index Ventures Patient Risk Capital Investment Main Business and Markets Served
-
Table Index Ventures Patient Risk Capital Investment Product Portfolio
-
Table New Enterprise Associates Company Details
-
Table New Enterprise Associates Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table New Enterprise Associates Patient Risk Capital Investment Main Business and Markets Served
-
Table New Enterprise Associates Patient Risk Capital Investment Product Portfolio
-
Table Greylock Partners Company Details
-
Table Greylock Partners Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Greylock Partners Patient Risk Capital Investment Main Business and Markets Served
-
Table Greylock Partners Patient Risk Capital Investment Product Portfolio
-
Table First Round Capital Company Details
-
Table First Round Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table First Round Capital Patient Risk Capital Investment Main Business and Markets Served
-
Table First Round Capital Patient Risk Capital Investment Product Portfolio
-
Table Benchmark Capital Company Details
-
Table Benchmark Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benchmark Capital Patient Risk Capital Investment Main Business and Markets Served
-
Table Benchmark Capital Patient Risk Capital Investment Product Portfolio
-
Table Founders Fund Company Details
-
Table Founders Fund Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Founders Fund Patient Risk Capital Investment Main Business and Markets Served
-
Table Founders Fund Patient Risk Capital Investment Product Portfolio
-
Table Kleiner Perkins Caufield Byers Company Details
-
Table Kleiner Perkins Caufield Byers Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kleiner Perkins Caufield Byers Patient Risk Capital Investment Main Business and Markets Served
-
Table Kleiner Perkins Caufield Byers Patient Risk Capital Investment Product Portfolio
-
Table Lowercase Capital Company Details
-
Table Lowercase Capital Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lowercase Capital Patient Risk Capital Investment Main Business and Markets Served
-
Table Lowercase Capital Patient Risk Capital Investment Product Portfolio
-
Table Baseline Ventures Company Details
-
Table Baseline Ventures Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baseline Ventures Patient Risk Capital Investment Main Business and Markets Served
-
Table Baseline Ventures Patient Risk Capital Investment Product Portfolio
-
Table Andreessen Horowitz Company Details
-
Table Andreessen Horowitz Patient Risk Capital Investment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Andreessen Horowitz Patient Risk Capital Investment Main Business and Markets Served
-
Table Andreessen Horowitz Patient Risk Capital Investment Product Portfolio
-
Figure Global Early Stage Financing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Expansion Financing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acquisition or Buyout Financing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global High Technology Industries Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Innovative Technology Company Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Table North America Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure United States Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure Germany Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure China Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure Brazil Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Patient Risk Capital Investment Consumption Forecast by Country (2022-2028)
-
Figure Australia Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Patient Risk Capital Investment Consumption Forecast and Growth Rate (2022-2028)
-

Chinese